These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7703832)
1. Effects of alpha-interferon on MHC unrestricted cytotoxicity in chronic myelogenous leukemia. Meseri-Delwail A; Delwail V; Brizard A; Goube de Laforest P; Guilhot F; Lecron JC Biotechnol Ther; 1994; 5(1-2):47-57. PubMed ID: 7703832 [TBL] [Abstract][Full Text] [Related]
2. Endogenous lymphokine activated killer cell activity and cytogenetic response in chronic myelogenous leukaemia treated with alpha-interferon. Meseri A; Delwail V; Brizard A; Lecron JC; Pelletier D; Guilhot F; Tanzer J; Goube de Laforest P Br J Haematol; 1993 Feb; 83(2):218-22. PubMed ID: 8457470 [TBL] [Abstract][Full Text] [Related]
3. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor. Chang WC; Hsiao MH; Pattengale PK Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400 [TBL] [Abstract][Full Text] [Related]
4. [Cytolytic activity by lymphokines (LAK activity) in chronic myeloid leukemia]. Cervantes F; Miller JS; McGlave PB Med Clin (Barc); 1995 Jun; 105(2):50-3. PubMed ID: 7603094 [TBL] [Abstract][Full Text] [Related]
5. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943 [TBL] [Abstract][Full Text] [Related]
6. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity. Reiter Z Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640 [TBL] [Abstract][Full Text] [Related]
7. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma. Muralikrishna K; Varalakshmi C; Khar A Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244 [TBL] [Abstract][Full Text] [Related]
8. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon. Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352 [TBL] [Abstract][Full Text] [Related]
9. [Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells]. Shi YX; Zhang XS; Xia JC; Li YQ; Xu RH; Han WJ; Zhang JH; Guan ZZ; Jiang WQ Ai Zheng; 2007 Aug; 26(8):837-42. PubMed ID: 17697543 [TBL] [Abstract][Full Text] [Related]
10. Restoration of Th1 cytokine synthesis by T cells of patients with chronic myelogenous leukemia in cytogenetic and hematologic remission with interferon-alpha. Reuben JM; Lee BN; Johnson H; Fritsche H; Kantarjian HM; Talpaz M Clin Cancer Res; 2000 May; 6(5):1671-7. PubMed ID: 10815885 [TBL] [Abstract][Full Text] [Related]
11. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum. Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757 [TBL] [Abstract][Full Text] [Related]
12. Antileukemia activity of a natural killer cell line against human leukemias. Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753 [TBL] [Abstract][Full Text] [Related]
13. Interleukin 2 protects hairy leukemic cells from lymphokine-activated killer cell-mediated cytotoxicity. Reiter Z; Taylor MW Cancer Res; 1993 Aug; 53(15):3555-60. PubMed ID: 7687924 [TBL] [Abstract][Full Text] [Related]
14. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells. Pattengale PK; Sundstrom C; Yu AL; Levine A Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341 [TBL] [Abstract][Full Text] [Related]
15. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts. Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628 [TBL] [Abstract][Full Text] [Related]
16. Altered IFNgamma signaling and preserved susceptibility to activated natural killer cell-mediated lysis of BCR/ABL targets. Cebo C; Voutsadakis IA; Da Rocha S; Bourhis JH; Jalil A; Azzarone B; Turhan AG; Chelbi-Alix M; Chouaib S; Caignard A Cancer Res; 2005 Apr; 65(7):2914-20. PubMed ID: 15805294 [TBL] [Abstract][Full Text] [Related]
17. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues. Colquhoun SD; Economou JS; Shau H; Golub SH J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167 [TBL] [Abstract][Full Text] [Related]
18. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells. Komatsu F; Kajiwara M Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151 [TBL] [Abstract][Full Text] [Related]
19. Different susceptibility of cervical keratinocytes containing human papillomavirus to cell-mediated cytotoxicity. Wu R; Coleman N; Stanley M Chin Med J (Engl); 1996 Nov; 109(11):854-8. PubMed ID: 9275369 [TBL] [Abstract][Full Text] [Related]
20. Regulation of natural killer function by nonlymphoid cells. Shau H; Roth MD; Golub SH Nat Immun; 1993; 12(4-5):235-49. PubMed ID: 8257829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]